The American Diabetes Association recently announced the recipients of two major research grants to support new studies on the effects of bariatric surgery in patients with type 2 diabetes. The American Diabetes Association Research Award Program in Bariatric Surgery in Diabetes, jointly sponsored by Covidien and Ethicon Endo-Surgery, awarded grants to Alyssa H. Hasty, PhD, from Vanderbilt University Medical Center and A. Gordon Smith, MD, from the University of Utah.

The American Diabetes Association Research Award Program in Bariatric Surgery in Diabetes will provide $1 million in funding to support two three-year research grants through the American Diabetes Association. One grant will fund Hasty`s research on the impact of bariatric surgery on reducing inflammation in adipose (fatty) tissue. The other grant will fund Smith`s work to examine the effect of bariatric surgery on the development of neuropathy. 

This award program is the first time these three organizations have worked together to fund research; Ethicon Endo-Surgery (EES) and Covidien are two of the world`s leading medical device companies in the fields of endoscopic and bariatric surgery.

"More research is needed to study the effects of bariatric surgery, particularly its implications for people with type 2 diabetes, especially with the nation`s growing epidemics of type 2 diabetes and obesity," said R. Robert Henry, MD, President, Medicine & Science, American Diabetes Association. "Research projects such as these will help further our understanding of these mechanisms."

"We know many bariatric surgery patients experience remission of type 2 diabetes within days of having surgery, before patients begin losing weight. Understanding why and how this happens may help us unlock new ways of treating type 2 diabetes and other co-morbidities of obesity," said Kenneth Sumner, PhD, Vice President, Worldwide Scientific Affairs, Ethicon Endo-Surgery. "We are delighted to support this important initiative as part of EES` Metabolic Applied Research Strategy (MARS)."

"A growing body of clinical evidence strongly suggests that bariatric surgery is a potentially life-transforming procedure, drastically improving both the physical and mental well-being of patients, and in many cases, completely resolving diabetes and other obesity-related co-morbidities," said Xavier P. Lefebvre, PhD, Global Vice-President, Clinical Affairs, Covidien. "We are proud to support these projects that have the potential to uncover new scientific insights into a promising and cost-effective solution for the obesity and diabetes epidemics affecting the global population."

American Diabetes Association Press Release

Originally posted by on August 31, 2011.